Goldman Sachs’s Milestone Pharmaceuticals MIST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $232K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $2.22M | Sell |
|
|||||
|
2024
Q3 | $2.06M | Hold |
|
|||||
|
2024
Q2 | $1.79M | Hold |
|
|||||
|
2024
Q1 | $2.42M | Hold |
|
|||||
|
2023
Q4 | $2.26M | Sell |
|
|||||
|
2023
Q3 | $7.93M | Buy |
|
|||||
|
2023
Q2 | $7.28M | Buy |
|
|||||
|
2023
Q1 | $10.1M | Sell |
|
|||||
|
2022
Q4 | $10.5M | Buy |
|
|||||
|
2022
Q3 | $960K | Buy |
|
|||||
|
2022
Q2 | $74K | Hold |
|
|||||
|
2022
Q1 | $77K | Hold |
|
|||||
|
2021
Q4 | $79K | Hold |
|
|||||
|
2021
Q3 | $69K | Hold |
|
|||||
|
2021
Q2 | $66K | Hold |
|
|||||
|
2021
Q1 | $70K | Sell |
|
|||||
|
2020
Q4 | $149K | Buy |
|
|||||
|
2020
Q3 | $88K | Buy |
|